Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.
Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference3%
- Check63 days agoChange DetectedSeveral links to external resources and specific clinical trial documents have been removed, which may affect access to important information regarding esophageal cancer and related studies.SummaryDifference4%
- Check70 days agoChange DetectedThe website has been updated to version v2.12.2, with new resources added including links to clinical trials, PubMed articles, and various health organization websites.SummaryDifference5%
Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.